Innovative Cosmetic Ingredients
Research and development of innovative cosmetic ingredients with proprietary chemical structures.
TRANSLATING SCIENCE INTO VALUE
Driven by unmet clinical needs and technological innovation, we provide outstanding health solutions for patients, physicians and pharmaceutical companies.
Focused on innovative healthcare product development and AI-enabled clinical research services.
ABOUT LONSCIENCE
ABOUT LONSCIENCE
Driven by unmet clinical needs and technological innovation, we provide outstanding health solutions for patients, physicians and pharmaceutical companies.
Founded in December 2021, Beijing Longxi Biotechnology Co., Ltd. is a biotechnology company driven by clinical value, focusing on innovative healthcare product development and AI-enabled clinical research services. Its core management team includes professionals from leading pharmaceutical companies, research institutes and other organizations in China and abroad, with multidisciplinary expertise spanning chemistry, pharmacy and clinical medicine.
DUAL-ENGINE STRATEGY
Innovative Healthcare Product Development ＋ AI-Enabled Clinical Research Services
Dual-Engine Growth
Industry–Academia–Research Collaboration
Lonscience actively promotes the integration of technological and industrial innovation. Through industry–academia–research collaboration with Capital Normal University, Shenyang Pharmaceutical University, Peking University International Hospital, and other academic and medical institutions, the company advances the efficient translation of research outcomes into industrial applications.
Innovative Drug Development
Product development guided by unmet clinical needs and practical healthcare value.
AI-Enabled Clinical Research Services
RemoData supports intelligent clinical data capture and management for post-marketing and real-world studies.
PRODUCTS / REMODATA
RemoData
Intelligent Clinical Data Capture and Management System
Making clinical data capture simpler and more efficient.
RemoData is independently developed by LONSCIENCE for post-marketing clinical studies and real-world studies. It combines OCR and AI-powered natural language processing to support de-identification, parsing and automated eCRF completion.
PRODUCTS / R&D PIPELINE
R&D PIPELINE
A diversified pipeline spanning novel compounds, new indications and differentiated generic medicines.
LS101
Innovative Cosmetic IngredientA depigmenting and skin-brightening cosmetic ingredient with a novel chemical structure and fully owned intellectual property rights. Designed on a prodrug principle, LS101 rapidly and efficiently penetrates the skin and maintains an effective concentration in the basal and dermal layers, with a visible brightening effect after approximately seven consecutive days of use.
Responding to growing public demand for health and beauty.LS205
Chemical Drug under China Categories 2.2 + 2.4A new drug developed on the basis of real-world evidence for neurological treatment, addressing an unmet treatment need in China and internationally.
Expanding treatment availability and supporting quality of life in older populations.LS311
Chemical Drug Substance and Oral Solution under China Category 3A drug substance and oral solution for the treatment of childhood epilepsy. No product of the same type is currently marketed in China. The project is included in the National Health Commission's List of Pediatric Drugs Encouraged for Research and Development and Application and in the WHO Model List of Essential Medicines for Children, and is consistently recommended as a first-line medicine in clinical guidelines in China and internationally. The upgraded technology replaces the conventional high-risk synthesis process for the drug substance.
A pediatric medicine intended to reduce adverse reactions associated with existing treatment.LS310
Oral Solution under China Chemical Drug Category 3An oral solution for local anaesthesia in cases of inflammation or pain affecting the oral and pharyngeal mucosa. No product of the same type is currently marketed in China.
An OTC-oriented product addressing broad public demand for an exclusive indication.NEWS / NEWS & INSIGHTS
News and Updates
Company News
View All Company NewsOfficial Website of Beijing Longxi Biotechnology Co., Ltd. Goes Live
The official website provides a new window for industry partners, institutions and the public to learn about LONSCIENCE.
Read More →Company NewsLONSCIENCE Recognized as a Technology-Based SME in Beijing
The recognition reflects continued progress in technological innovation, R&D development and research translation.
Read More →Company NewsLONSCIENCE Recognized as a Beijing Specialized, Sophisticated, Distinctive and Innovative SME
The company has made further progress in specialized development, technological innovation and R&D capability building.
Read More →Company NewsLONSCIENCE Recognized as a Beijing Innovative SME
The company's innovation capabilities, R&D system and development potential have received further recognition.
Read More →CAREERS
Build an innovation benchmark in healthcare with us.
Join professionals who respect science, value expertise and work to create lasting value for patients, partners and society.
View CareersCONTACT
Contact Us
For information about RemoData, our R&D pipeline or other business matters, please contact us.
Send an EmailEMAILlongxi@lonscience.comADDRESS
Room 1821, North Tower, Building B, Huatong Building, No. 19B Chegongzhuang West Road, Haidian District, Beijing, China